Latest News
Featured News
Scancell updated Phase 2 data shows continued improvement in progression free survival with iSCIB1+
Welcome to WordPress. This is your first post. Edit or delete it, then start writing!
Select the category
Scancell to present at the Annual Immuno-Oncology Summit Europe
Scancell to Present at 2024 AACR Annual Meeting
First Patient dosed with iSCIB1+ in SCOPE trial
Appointment of Sath Nirmalananthan to the Board of Directors
Scancell Announces its Attendance at Upcoming Conferences
Scancell Attends and Sponsors the Annual Melanoma Patient Meeting
No results found.
Regulatory News Archive
JOIN OUR MAILING LIST
Sign up for news updates to stay up to date with Scancell.